Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 2/2008

01-02-2008 | Original Paper

Echocardiographic features of patients with paroxysmal atrial fibrillation

Authors: Yucel Colkesen, Tayfun Acil, Senol Demircan, Alpay T. Sezgin, Bulent Ozin, Haldun Muderrisoglu

Published in: The International Journal of Cardiovascular Imaging | Issue 2/2008

Login to get access

Abstract

Background. There are several risk factors for the initiation of paroxysmal atrial fibrillation (PAF) and the underlying mechanisms are multifactorial. Our study aims to explore the echocardiographic parameters that can identify in patients with PAF compared to normal subjects. Methods. Eighty consecutive patients who were with PAF detected by 24-h Holter monitoring (HM) were assigned in our study. The control group (n = 80) consisted individuals with no PAF on HM. Indication for HM was palpitations at rest. All patients underwent routine echocardiographic evaluation. Patients with aortic and mitral stenosis, hyperthyroidism, and hypothyroidism were excluded from the study. Comprehensive clinical data were collected. Results. Mean age of the patients with PAF was 63 ± 11 years and of those 42% were male subjects. There was no difference in the prevalence of hypertension in both groups. Mean left ventricular ejection fraction (LVEF) was 57 ± 15% in PAF group and 64 ± 2% in control subjects (p < 0.001). Mean values of left atrial (LA) diameter for PAF and control groups were 3.7 ± 0.6 cm vs. 3.1 ± 0.4 cm (p < 0.001), respectively. Patients with PAF had more severe valve insufficiency, higher values of mean pulmonary artery systolic pressures (PAP) (29 ± 10 mmHg vs. 25 ± 2 mmHg, respectively; p = 0.001) and deteriorated MV inflow velocities (E:A ratio 0.9 ± 0.4 vs. 1.1 ± 0.3, respectively; p = 0.008) when compared to control group. In multivariate logistic regression analysis, LA diameter predicted the development of PAF after adjusted for age and gender. Conclusion. Our results indicate that LA diameter predicts the development of PAF.
Literature
1.
go back to reference Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S (2006) Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with AF-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27(16):1979–2030 Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S (2006) Task Force on Practice Guidelines, American College of Cardiology/American Heart Association; Committee for Practice Guidelines, European Society of Cardiology; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with AF-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation). Eur Heart J 27(16):1979–2030
2.
go back to reference Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, van Wagoner DR, Waldo AL (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103(5):769–777PubMed Allessie MA, Boyden PA, Camm AJ, Kleber AG, Lab MJ, Legato MJ, Rosen MR, Schwartz PJ, Spooner PM, van Wagoner DR, Waldo AL (2001) Pathophysiology and prevention of atrial fibrillation. Circulation 103(5):769–777PubMed
3.
go back to reference Kannel WB, Wolf PA, Benjamin EJ, et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9NPubMedCrossRef Kannel WB, Wolf PA, Benjamin EJ, et al (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9NPubMedCrossRef
4.
go back to reference Chung MK, Burkhardt JD, Klein AL (2005) Strategies for stroke prevention in atrial fibrillation. Heart Rhythm 2(1):103–106PubMedCrossRef Chung MK, Burkhardt JD, Klein AL (2005) Strategies for stroke prevention in atrial fibrillation. Heart Rhythm 2(1):103–106PubMedCrossRef
5.
go back to reference Tang RB, Dong JZ, Liu XP, Ma CS (2006) Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation? Med Hypotheses 67(3):462–466PubMedCrossRef Tang RB, Dong JZ, Liu XP, Ma CS (2006) Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation? Med Hypotheses 67(3):462–466PubMedCrossRef
6.
go back to reference Boos CJ, Anderson RA, Lip GY (2006) Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27:136–149PubMedCrossRef Boos CJ, Anderson RA, Lip GY (2006) Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27:136–149PubMedCrossRef
7.
go back to reference Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48(3):e1–e148 Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O’Gara PT, O’Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 48(3):e1–e148
8.
9.
go back to reference Vaturi M, Sagie A, Shapira Y, Feldman A, Fink N, Strasberg B, Adler Y (2001) Impact of atrial fibrillation on clinical status, atrial size and hemodynamics in patients after mitral valve replacement. J Heart Valve Dis 10(6):763–766PubMed Vaturi M, Sagie A, Shapira Y, Feldman A, Fink N, Strasberg B, Adler Y (2001) Impact of atrial fibrillation on clinical status, atrial size and hemodynamics in patients after mitral valve replacement. J Heart Valve Dis 10(6):763–766PubMed
10.
go back to reference Hagens VE, van Veldhuisen DJ, Kamp O, Rienstra M, Bosker HA, Veeger NJ, Tijssen JG, Crijns HJ, van Gelder IC (2005) RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm 2(1):19–24PubMedCrossRef Hagens VE, van Veldhuisen DJ, Kamp O, Rienstra M, Bosker HA, Veeger NJ, Tijssen JG, Crijns HJ, van Gelder IC (2005) RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study. Heart Rhythm 2(1):19–24PubMedCrossRef
11.
go back to reference Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL (2005) Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 45(12):2026–2033PubMedCrossRef Olshansky B, Heller EN, Mitchell LB, Chandler M, Slater W, Green M, Brodsky M, Barrell P, Greene HL (2005) Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 45(12):2026–2033PubMedCrossRef
12.
go back to reference Wozakowska-Ka plon B (2005) Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period. Int J Cardiol 101(1):47–52CrossRef Wozakowska-Ka plon B (2005) Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period. Int J Cardiol 101(1):47–52CrossRef
13.
go back to reference Volgman AS, Soble JS, Neumann A, Mukhtar KN, Iftikhar F, Vallesteros A, Liebson PR (1996) Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging 10(4):261–265PubMed Volgman AS, Soble JS, Neumann A, Mukhtar KN, Iftikhar F, Vallesteros A, Liebson PR (1996) Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging 10(4):261–265PubMed
14.
go back to reference Barbier P, Alioto G, Guazzi MD (1994) Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 24(1):165–170PubMedCrossRef Barbier P, Alioto G, Guazzi MD (1994) Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 24(1):165–170PubMedCrossRef
Metadata
Title
Echocardiographic features of patients with paroxysmal atrial fibrillation
Authors
Yucel Colkesen
Tayfun Acil
Senol Demircan
Alpay T. Sezgin
Bulent Ozin
Haldun Muderrisoglu
Publication date
01-02-2008
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 2/2008
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-007-9247-3

Other articles of this Issue 2/2008

The International Journal of Cardiovascular Imaging 2/2008 Go to the issue